Acne VulgarisNCT07652112
AI-Generated Acne Vulgaris Learning Material Study
A study testing Artificial Intelligence-Generated Acne Vulgaris Educational Material and Turkish Dermatology Association Acne Vulgaris Educational Material in people with Acne Vulgaris and Medical Education, run by Hasan Durmuş at 1 site in Turkey (Türkiye).
Trial summary
This comparative educational intervention study evaluated the educational effectiveness of artificial intelligence-generated patient information material on acne vulgaris among early-year medical students. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Acne Vulgaris, Medical Education
- What is being tested?
- Artificial Intelligence-Generated Acne Vulgaris Educational Material and Turkish Dermatology Association Acne Vulgaris Educational Material
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 190 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Sep 2025to 15 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- First- and second-year medical students enrolled at Erciyes University Faculty of Medicine
- Voluntary participation in the study
- Provision of informed consent
Who cannot join
- Students who declined to participate
- Students who did not complete the knowledge assessment questionnaire
- Students with incomplete study data
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluating AI-Generated Educational Material for Acne Vulgaris Learning Among Early-Year Medical Students: A Comparative Educational Intervention Study
This comparative educational intervention study evaluated the educational effectiveness of artificial intelligence-generated patient information material on acne vulgaris among early-year medical students. In the first phase, acne vulgaris information texts were generated using different artificial intelligence models and evaluated by two dermatologists using quality and understandability assessment tools. In the second phase, the best-performing artificial intelligence-generated material was compared with standard human-generated material from the Turkish Dermatology Association and a control group. A total of 190 first- and second-year medical students at Erciyes University Faculty of Medicine participated in the study. Participants were divided into three groups: artificial intelligence-generated material group, Turkish Dermatology Association material group, and control group. After the educational materials were presented, participants completed a 12-question knowledge assessment questionnaire on acne vulgaris.
- Conditions
- Acne Vulgaris, Medical Education
- Being tested
- Artificial Intelligence-Generated Acne Vulgaris Educational Material, Turkish Dermatology Association Acne Vulgaris Educational Material
- Keywords
- Artificial Intelligence, Patient Education, Medical Education, Educational Intervention
- Medical subject headings
- Acne Vulgaris
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Artificial Intelligence-Generated Acne Vulgaris Educational MaterialOther
Educational material on acne vulgaris generated using an artificial intelligence model and presented to participants.
Turkish Dermatology Association Acne Vulgaris Educational MaterialOther
Standard human-generated educational material on acne vulgaris provided by the Turkish Dermatology Association and presented to participants.
| Study group | Role | What they receive |
|---|---|---|
| Artificial Intelligence-Generated Material Group | Experimental | Participants received educational material on acne vulgaris generated by the best-performing artificial intelligence model. Receives: Other: Artificial Intelligence-Generated Acne Vulgaris Educational Material |
| Turkish Dermatology Association Material Group | Active comparator | Participants received standard human-generated educational material on acne vulgaris provided by the Turkish Dermatology Association. Receives: Other: Turkish Dermatology Association Acne Vulgaris Educational Material |
| Control Group | No intervention | Participants did not receive the educational material before completing the knowledge assessment questionnaire. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acne Vulgaris Knowledge Score
Acne vulgaris knowledge level was assessed using a 12-question knowledge assessment questionnaire administered after the educational intervention.
Measured: Immediately after the educational intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jun 2026
- Study start15 Sep 2025
- Primary completion15 Dec 2025
- Study completion15 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acne VulgarisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Participants were assigned to one of three parallel groups: artificial intelligence-generated material group, Turkish Dermatology Association material group, or control group.
- Masking
- None (open label)
- Enrolment
- 190 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hasan Durmuş
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Hasan Durmuş, TC Erciyes University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07652112
- Sponsor's protocol ID
- ERU-AIACNE-2025-01
- Status last verified
- Jun 2026
- First submitted
- 11 Jun 2026
- Last updated
- 16 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be publicly shared due to privacy and ethical considerations. De-identified data may be available from the corresponding author upon reasonable request.
Study at a glance
From the registry record, last updated by the sponsor on 16 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating AI-Generated Educational Material for Acne Vulgaris Learning Among Early-Year Medical Students: A Comparative Educational Intervention Study
- ClinicalTrials.gov ID
- NCT07652112
- Acronym / sponsor ID
- ERU-AIACNE-2025-01
- Conditions
- Acne Vulgaris, Medical Education
- Keywords
- Artificial Intelligence, Patient Education, Medical Education, Educational Intervention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 190 participants (actual)
- Lead sponsor
- Hasan DurmuşUniversity, hospital or other
- Study start
- 15 Sep 2025 (actual)
- Primary completion
- 15 Dec 2025 (actual)
- Study completion
- 15 Mar 2026 (actual)
- First posted
- 16 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This comparative educational intervention study evaluated the educational effectiveness of artificial intelligence-generated patient information material on acne vulgaris among early-year medical students. In the first phase, acne vulgaris information texts were generated using different artificial intelligence models and evaluated by two dermatologists using quality and understandability assessment tools. In the second phase, the best-performing artificial intelligence-generated material was compared with standard human-generated material from the Turkish Dermatology Association and a control group. A total of 190 first- and second-year medical students at Erciyes University Faculty of Medicine participated in the study. Participants were divided into three groups: artificial intelligence-generated material group, Turkish Dermatology Association material group, and control group. After the educational materials were presented, participants completed a 12-question knowledge assessment questionnaire on acne vulgaris.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- Participants were assigned to one of three parallel groups: artificial intelligence-generated material group, Turkish Dermatology Association material group, or control group.
| Arm | Type | Receives |
|---|---|---|
| Artificial Intelligence-Generated Material Group | Experimental | Other: Artificial Intelligence-Generated Acne Vulgaris Educational MaterialParticipants received educational material on acne vulgaris generated by the best-performing artificial intelligence model. |
| Turkish Dermatology Association Material Group | Active comparator | Other: Turkish Dermatology Association Acne Vulgaris Educational MaterialParticipants received standard human-generated educational material on acne vulgaris provided by the Turkish Dermatology Association. |
| Control Group | No intervention | –Participants did not receive the educational material before completing the knowledge assessment questionnaire. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- First- and second-year medical students enrolled at Erciyes University Faculty of Medicine
- Voluntary participation in the study
- Provision of informed consent
Key exclusion criteria (3 listed)
- Students who declined to participate
- Students who did not complete the knowledge assessment questionnaire
- Students with incomplete study data
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Artificial Intelligence-Generated Acne Vulgaris Educational MaterialEducational material on acne vulgaris generated using an artificial intelligence model and presented to participants. | Other | Artificial Intelligence-Generated Material Group |
| Turkish Dermatology Association Acne Vulgaris Educational MaterialStandard human-generated educational material on acne vulgaris provided by the Turkish Dermatology Association and presented to participants. | Other | Turkish Dermatology Association Material Group |
Primary outcome
Acne Vulgaris Knowledge Score
Time frame: Immediately after the educational intervention
Acne vulgaris knowledge level was assessed using a 12-question knowledge assessment questionnaire administered after the educational intervention.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jun 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be publicly shared due to privacy and ethical considerations. De-identified data may be available from the corresponding author upon reasonable request.
Related trials for Acne Vulgaris
RecruitingPhase 3
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Acne Vulgaris
Recruiting
Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne Vulgaris
Acne Vulgaris
RecruitingPhase 1
Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne
Acne
Active, not recruitingPhase 2
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Hidradenitis Suppurativa (HS)
Not yet recruitingPhase 4
Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne
Acne Vulgaris
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Artificial Intelligence-Generated Acne Vulgaris Educational Material and Turkish Dermatology Association Acne Vulgaris Educational Material in people with Acne Vulgaris and Medical Education, run by Hasan Durmuş at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acne Vulgaris Knowledge Score (time frame: Immediately after the educational intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026.